Novo Nordisk | NVO - حساب الفائدة على الديون





حساب الفائدة على الديون تغيير تاريخ
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 230K 1.88M 2026-03
Bausch Health Companies USD 402M 5M 2026-03
Bristol-Myers Squibb USD 407M 4M 2026-06
Canopy Growth CAD 12.31M 4.97M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Drreddys Laboratories INR 1.06B 113M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
GlaxoSmithKline GBP 121M 46M 2026-06
Merck USD 479M 67M 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 462M 119M 2026-06
Novo Nordisk DKK 1.53B 3.43B 2025-09
Pacira USD 3.7M 193K 2026-03
Perrigo USD 7.98B 7.94B 2026-03
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Sanofi EUR 287M 109M 2026-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
Zoetis USD 62M 5M 2026-03